Stifel analyst Alex Thompson is reiterating a Buy rating on Kymera Therapeutics (KYMR) following “a slate of updates,” including the decision by partner Sanofi (SNY) to discontinue development of...
The Wall Street Journal had an interesting piece (reposted on Realtor.com) about New York City’s Mayoral primary that subsequently took place on June, 24th. Their article suggested that NYC’s housing crisis has reached such epic...
New Delhi: Despite losing Generalized System of Preferences (GSP) status under the Trump administration's first term, India's trade with the United States demonstrated...